The movement toward personalized treatments with immunomodulatory effects has made testing biomarkers of immunomodulation increasingly important. Careful monitoring of complement factors and cytokines can help prevent any unintended consequences that may arise from these new medications.

In this eBook, Altasciences shares comprehensive information about including the testing of these biomarkers in your drug development program.

Contents include:

• REVIEW: Complement Factors and Cytokines

• SOLUTIONS: Biomarker Analysis

• CASE STUDY: Comparing Cytokine Data to In-Life Parameters on Nonhuman Primates in Nonclinical Toxicology Studies

Click here to download a readable, PDF version of this eBook: https://www.altasciences.com/sites/default/files/2022-06/Key_Biomarkers_of_Immunomodulation.pdf

About Altasciences:

Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.